These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 35964682)

  • 1. Hypermethylation in the promoter region of the ADRA1A gene is associated with opioid use disorder in Han Chinese.
    Zhang J; Fu X; Lu Y; Cheng C; Wang K; Zhu Y; Xie Q
    Brain Res; 2022 Oct; 1793():148050. PubMed ID: 35964682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between methylation in the promoter region of the GAD2 gene and opioid use disorder.
    Tang H; Zhang Y; Xun Y; Yu J; Lu Y; Zhang R; Dang W; Zhu F; Zhang J
    Brain Res; 2023 Aug; 1812():148407. PubMed ID: 37182687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid Exposure is Associated with Aberrant DNA Methylation of OPRM1 Promoter Region in a Chinese Han Population.
    Xu J; Wang T; Su Z; Zhou X; Xiang Y; He L; Li C; Yang Z; Zhao X
    Biochem Genet; 2018 Oct; 56(5):451-458. PubMed ID: 29564682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation and expression quantitative trait locus rs6296 in the HTR1B gene is associated with susceptibility to opioid use disorder.
    Li Y; Lu Y; Xie Q; Zeng X; Zhang R; Dang W; Zhu Y; Zhang J
    Psychopharmacology (Berl); 2022 Aug; 239(8):2515-2523. PubMed ID: 35438303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation quantitative trait locus rs5326 is associated with susceptibility and effective dosage of methadone maintenance treatment for heroin use disorder.
    Zhang J; Fan Y; Zhou J; Ma T; Gao K; Xu M; Xiao Y; Zhu Y
    Psychopharmacology (Berl); 2021 Dec; 238(12):3511-3518. PubMed ID: 34476566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts.
    Nielsen DA; Yuferov V; Hamon S; Jackson C; Ho A; Ott J; Kreek MJ
    Neuropsychopharmacology; 2009 Mar; 34(4):867-73. PubMed ID: 18650805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter aberrant methylation status of
    Chen G; Fan X; Li Y; He L; Wang S; Dai Y; Bin C; Zhou D; Lin H
    Epigenetics; 2020; 15(6-7):684-701. PubMed ID: 31933413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of DNA Methylation in the Promoter Regions of the Brain-Derived Neurotrophic Factor Gene is Associated with Heroin Addiction.
    Xiao Y; Zhu Y; Li Y
    J Mol Neurosci; 2021 Sep; 71(9):1752-1760. PubMed ID: 34173192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter.
    Sandoval-Sierra JV; Salgado García FI; Brooks JH; Derefinko KJ; Mozhui K
    Clin Epigenetics; 2020 Jun; 12(1):76. PubMed ID: 32493461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts.
    Chorbov VM; Todorov AA; Lynskey MT; Cicero TJ
    J Opioid Manag; 2011; 7(4):258-64. PubMed ID: 21957825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study on methylation of two CpG islands of MAOA gene promoter among opium-addicted males undergoing methadone treatment.
    Omarmeli V; Sharafshah A; Albonaim A; Keshavarz P
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(9):841-850. PubMed ID: 35759647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of DNA methylation at the OPRM1 promoter region in men with opioid use disorder.
    Ebrahimi G; Asadikaram G; Akbari H; Nematollahi MH; Abolhassani M; Shahabinejad G; Khodadadnejad L; Hashemi M
    Am J Drug Alcohol Abuse; 2018; 44(2):193-199. PubMed ID: 28121474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic and sex differences in opioid use disorder in chronic pain: A real-world study linked with OPRM1 DNA methylation.
    Agulló L; Escorial M; Orutño S; Muriel J; Sandoval J; Margarit C; Peiró AM
    Addict Biol; 2024 Jul; 29(7):e13422. PubMed ID: 38949208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation quantitative locus rs3758653 in the DRD4 gene is associated with duration from first heroin exposure to addiction.
    Zhang R; Dang W; Zhang J; He R; Li G; Zhang L; Wang Z; Zong H; Liu N; Jia W
    Brain Res; 2022 Jan; 1775():147746. PubMed ID: 34864042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts.
    Nielsen DA; Hamon S; Yuferov V; Jackson C; Ho A; Ott J; Kreek MJ
    Hum Genet; 2010 Jun; 127(6):639-49. PubMed ID: 20237803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of Catechol-o-methyltransferase and Alpha-1-adrenergic receptor gene polymorphisms with multiple phenotypes of heroin use disorder.
    Deji C; Li Y; Chen Y; Lai J; Wei S
    Neurosci Lett; 2021 Mar; 748():135677. PubMed ID: 33577997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation and expression quantitative trait loci rs1799971 in the OPRM1 gene and rs4654327 in the OPRD1 gene are associated with opioid use disorder.
    Yu J; Zhang Y; Xun Y; Tang H; Fu X; Zhang R; Zhu F; Zhang J
    Neurosci Lett; 2023 Sep; 814():137468. PubMed ID: 37660978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of the
    Liu L; Yang X; Zhao F; Gao C; Zhang N; Bao J; Li K; Zhang X; Lu X; Ruan Y; Zhong S
    Am J Drug Alcohol Abuse; 2021 Nov; 47(6):694-703. PubMed ID: 34582308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report.
    Abdolmaleky HM; Cheng KH; Russo A; Smith CL; Faraone SV; Wilcox M; Shafa R; Glatt SJ; Nguyen G; Ponte JF; Thiagalingam S; Tsuang MT
    Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):60-6. PubMed ID: 15717292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.